$Vanguard S&P 500 ETF(VOO.US)$ do you set stop loss for this stock? how much? 10%?

$Amazon(AMZN.US)$ informed customers that "starting 19 January 2022, we will no longer accept $Visa(V.US)$  credit cards issued in the U.K." due to the high fees charged by Visa to process transactions, Bloomberg reports.
Amazon customers can still use Visa debit cards, MasterCard, Amex credit cards, Visa credit cards issued outside the U.K.
"We are very disappointed that Amazon is threatening to restrict consumer choice in the future. When consumer choice is limited, nobody wins," a Visa spokesman said. "We have a long-standing relationship with Amazon, and we continue to work toward a resolution."
Analyst rating: Baird analyst David Koning who made no change to his Outperform rating on Visa, believes this is immaterial for several reasons, including that consumers can still use debit cards, which likely generate the exact yield to Visa, as well as that the U.K. in total is "maybe around 6%" to Visa revenue and Amazon a small part of that.
While not material, Koning believes the news is a sentiment headwind, but likes Visa and expects growth over the next few years to be faster than usual.

$Advanced Micro Devices(AMD.US)$ $NVIDIA(NVDA.US)$ 
"The valuation tilts the scales in favor of AMD
AMD is trading at 40 times trailing earnings, which makes it much cheaper than Nvidia, which trades at 95 times trailing earnings. Also, AMD's price-to-sales ratio of 10.7 is much lower than Nvidia's multiple of 30.7.
Choosing AMD stock over Nvidia right now looks like a no-brainer. AMD is expected to outpace Nvidia's growth, it has a broader range of catalysts, and is substantially cheaper -- making it an ideal bet for investors looking to buy one of these two growth stocks right now".

$CVS Health(CVS.US)$ CVS Health (CVS) with a host of target raises. Average price target $110 at Buy. Stock currently around $95
$Electronic Arts Inc(EA.US)$ Electronic Arts (EA) with four target raises. Stock currently around $143
Robert W Baird from $1170 to $175 at Outperform
Credit Suisse from$175 to $177 at Outperform
Rayond James from $177 to $185 at Outperform
$Generac(GNRC.US)$ Generac (GNRC) with two target raises. Stock currently around $450
Citigroup from $520 to $560 at Buy
Argus from $475 to $510

$Bumble(BMBL.US)$ Buy AMC instead first, short squeeze is coming soon. Institutional investor are selling some of their long position (in good companies) to join AMC squeeze. The bad Institutional investor on the other hand is shorting amc stocks, but majority institutional investor are long amc, meaning AMC squeeze is coming soon. If you don't believe check google and do your due dilligent..., even the greatest trader of all times, Jims Simmons also tripled his stake in AMC, signifying AMC squeeze is somewhere around the corner. If you do not know him, he has a track record of consistent 40% return over 20 consecutive years. He can't be that much of a wrong. Believe in the APES movement, I really dont want anybody to lose any money bc of this short term plays....

$Airbnb(ABNB.US)$ Wall Street expects Airbnb to earn 75 cents per share on revenue of 2.04 billion U.S. dollars.
Aspect: Can Airbnb maintain a high valuation? Although the company created the home-sharing market, the delta variant of the coronavirus may weaken the company's growth plans. In the past six months, Airbnb’s stock price has fallen by 5%, while the S&P 500 has risen by 10%. This shows that Wall Street is rethinking the value of these stocks, which have outperformed Expedia (EXPE) and TripAdvisor (TRIP).
But Airbnb has an attractive business model and competitive advantage, and is considered superior to its competitors. The company is arguably the most attractive stock in the travel and accommodation industry.
Article excerpted from the US Stock Research Agency

$Bumble(BMBL.US)$ Hopeless for now, join AMC instead for squeeze and return to bumble. Trust me AMC is taking off.

$Vanguard Total Stock Market ETF(VTI.US)$ $Vanguard Total Stock Market ETF(VTI.US)$ If you want a consistent performer that does not require you to do heavy monitoring, this is a good option. You won't get those dramatic increases. But no dramatic reductiobs either.